| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,191 |
10,503 |
$1.42M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,450 |
8,783 |
$1.40M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,561 |
10,000 |
$972K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,041 |
3,792 |
$162K |
| 71046 |
Radiologic examination, chest; 2 views |
3,445 |
3,325 |
$151K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
365 |
342 |
$135K |
| 80053 |
Comprehensive metabolic panel |
15,967 |
13,822 |
$130K |
| 70450 |
Computed tomography, head or brain; without contrast material |
959 |
888 |
$102K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,978 |
5,288 |
$98K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,819 |
12,925 |
$98K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,649 |
1,362 |
$93K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,047 |
799 |
$92K |
| 71045 |
Radiologic examination, chest; single view |
3,205 |
2,958 |
$85K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
73 |
69 |
$84K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
336 |
265 |
$80K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,271 |
1,248 |
$68K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,287 |
1,146 |
$62K |
| G0378 |
Hospital observation service, per hour |
490 |
412 |
$49K |
| 83880 |
|
2,405 |
2,269 |
$46K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,235 |
2,692 |
$45K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,314 |
2,499 |
$43K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,471 |
2,460 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,818 |
2,522 |
$35K |
| 81001 |
|
11,283 |
10,425 |
$34K |
| 36415 |
Collection of venous blood by venipuncture |
16,395 |
14,855 |
$32K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
163 |
101 |
$27K |
| 81025 |
|
3,695 |
3,414 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
407 |
355 |
$24K |
| 84484 |
|
5,330 |
3,728 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
576 |
556 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
449 |
427 |
$16K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
25 |
24 |
$16K |
| J3490 |
Unclassified drugs |
2,895 |
1,404 |
$15K |
| 85730 |
|
3,384 |
3,153 |
$11K |
| Q3014 |
Telehealth originating site facility fee |
234 |
198 |
$10K |
| 11045 |
|
42 |
14 |
$8K |
| 83690 |
|
1,466 |
1,380 |
$8K |
| 86592 |
|
426 |
369 |
$8K |
| 85610 |
|
3,473 |
3,244 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
393 |
318 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
740 |
694 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$5K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
59 |
25 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
102 |
98 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
58 |
45 |
$4K |
| A9270 |
Non-covered item or service |
5,299 |
2,272 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
294 |
283 |
$4K |
| 87807 |
|
312 |
298 |
$3K |
| 85027 |
|
529 |
462 |
$2K |
| 81002 |
|
895 |
743 |
$2K |
| 80320 |
|
23 |
13 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,177 |
1,848 |
$2K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
58 |
51 |
$2K |
| 36591 |
|
65 |
37 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
25 |
25 |
$917.02 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
160 |
144 |
$691.11 |
| 73610 |
|
12 |
12 |
$635.58 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
12 |
$531.16 |
| 85007 |
|
172 |
162 |
$478.97 |
| 83605 |
|
80 |
65 |
$474.17 |
| 87040 |
|
134 |
69 |
$427.58 |
| 84145 |
|
24 |
24 |
$363.86 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
143 |
103 |
$361.07 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$283.26 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$283.26 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
140 |
129 |
$220.29 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
121 |
98 |
$219.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49 |
47 |
$197.90 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
105 |
79 |
$187.08 |
| 82728 |
|
13 |
12 |
$113.98 |
| 86140 |
|
24 |
24 |
$101.55 |
| 87210 |
|
25 |
24 |
$95.00 |
| 85379 |
|
13 |
13 |
$80.36 |
| 83550 |
|
13 |
12 |
$73.47 |
| 83540 |
|
13 |
12 |
$56.42 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
12 |
12 |
$44.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
13 |
$16.86 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
12 |
12 |
$0.00 |